These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 29728332)
1. 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in service personnel. Cipriani A; Cowen PJ Lancet Psychiatry; 2018 Jun; 5(6):453-455. PubMed ID: 29728332 [No Abstract] [Full Text] [Related]
2. 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial. Mithoefer MC; Mithoefer AT; Feduccia AA; Jerome L; Wagner M; Wymer J; Holland J; Hamilton S; Yazar-Klosinski B; Emerson A; Doblin R Lancet Psychiatry; 2018 Jun; 5(6):486-497. PubMed ID: 29728331 [TBL] [Abstract][Full Text] [Related]
3. A randomized, controlled pilot study of MDMA (± 3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD). Oehen P; Traber R; Widmer V; Schnyder U J Psychopharmacol; 2013 Jan; 27(1):40-52. PubMed ID: 23118021 [TBL] [Abstract][Full Text] [Related]
4. 3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: A randomized phase 2 controlled trial. Ot'alora G M; Grigsby J; Poulter B; Van Derveer JW; Giron SG; Jerome L; Feduccia AA; Hamilton S; Yazar-Klosinski B; Emerson A; Mithoefer MC; Doblin R J Psychopharmacol; 2018 Dec; 32(12):1295-1307. PubMed ID: 30371148 [TBL] [Abstract][Full Text] [Related]
5. MDMA assisted psychotherapy found to have a large effect for chronic post-traumatic stress disorder. Chabrol H J Psychopharmacol; 2013 Sep; 27(9):865-6. PubMed ID: 23981728 [No Abstract] [Full Text] [Related]
6. A comparison of MDMA-assisted psychotherapy to non-assisted psychotherapy in treatment-resistant PTSD: A systematic review and meta-analysis. Illingworth BJ; Lewis DJ; Lambarth AT; Stocking K; Duffy JM; Jelen LA; Rucker JJ J Psychopharmacol; 2021 May; 35(5):501-511. PubMed ID: 33345689 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for posttraumatic stress disorder: A systematic review and meta-analysis. Bahji A; Forsyth A; Groll D; Hawken ER Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jan; 96():109735. PubMed ID: 31437480 [TBL] [Abstract][Full Text] [Related]
9. MDMA-assisted psychotherapy for posttraumatic stress disorder: A promising novel approach to treatment. Vermetten E; Yehuda R Neuropsychopharmacology; 2020 Jan; 45(1):231-232. PubMed ID: 31455855 [No Abstract] [Full Text] [Related]
10. Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials. Jerome L; Feduccia AA; Wang JB; Hamilton S; Yazar-Klosinski B; Emerson A; Mithoefer MC; Doblin R Psychopharmacology (Berl); 2020 Aug; 237(8):2485-2497. PubMed ID: 32500209 [TBL] [Abstract][Full Text] [Related]
11. [Therapeutic investigation with MDMA (ecstasy)]. Bouso Saiz JC; Gómez-Jarabo G Med Clin (Barc); 2003 Sep; 121(8):318; author reply 318-9. PubMed ID: 14499096 [No Abstract] [Full Text] [Related]
12. Acute subjective effects in LSD- and MDMA-assisted psychotherapy. Schmid Y; Gasser P; Oehen P; Liechti ME J Psychopharmacol; 2021 Apr; 35(4):362-374. PubMed ID: 33853422 [TBL] [Abstract][Full Text] [Related]
13. Discontinuation of medications classified as reuptake inhibitors affects treatment response of MDMA-assisted psychotherapy. Feduccia AA; Jerome L; Mithoefer MC; Holland J Psychopharmacology (Berl); 2021 Feb; 238(2):581-588. PubMed ID: 33221932 [TBL] [Abstract][Full Text] [Related]
14. Beyond ecstasy: Alternative entactogens to 3,4-methylenedioxymethamphetamine with potential applications in psychotherapy. Oeri HE J Psychopharmacol; 2021 May; 35(5):512-536. PubMed ID: 32909493 [TBL] [Abstract][Full Text] [Related]
15. The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study. Mithoefer MC; Wagner MT; Mithoefer AT; Jerome L; Doblin R J Psychopharmacol; 2011 Apr; 25(4):439-52. PubMed ID: 20643699 [TBL] [Abstract][Full Text] [Related]
16. Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study. Mithoefer MC; Wagner MT; Mithoefer AT; Jerome L; Martin SF; Yazar-Klosinski B; Michel Y; Brewerton TD; Doblin R J Psychopharmacol; 2013 Jan; 27(1):28-39. PubMed ID: 23172889 [TBL] [Abstract][Full Text] [Related]
17. Is the 3,4-Methylenedioxymethamphetamine assisted psychotherapy a novel approach to managing post-traumatic stress disorder? Nafees T; Wase HA; Amir Malik MF J Pak Med Assoc; 2019 Aug; 69(8):1229. PubMed ID: 31431790 [No Abstract] [Full Text] [Related]
19. MDMA-assisted psychotherapy using low doses in a small sample of women with chronic posttraumatic stress disorder. Bouso JC; Doblin R; Farré M; Alcázar MA; Gómez-Jarabo G J Psychoactive Drugs; 2008 Sep; 40(3):225-36. PubMed ID: 19004414 [TBL] [Abstract][Full Text] [Related]
20. The efficacy and safety of MDMA-assisted psychotherapy for treatment of posttraumatic stress disorder: A systematic review and meta-analysis from randomized controlled trials. Yang J; Wang N; Luo W; Gao J Psychiatry Res; 2024 Sep; 339():116043. PubMed ID: 38896930 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]